{
    "2018-10-29": [
        [
            {
                "time": "",
                "original_text": "上海医药（601607）2018年三季报点评：工商齐发力，业绩再提速",
                "features": {
                    "keywords": [
                        "上海医药",
                        "三季报",
                        "工商",
                        "业绩",
                        "提速"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药开启“买买买”模式 123亿商誉占比3成净资产",
                "features": {
                    "keywords": [
                        "上海医药",
                        "买买买",
                        "商誉",
                        "净资产"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "上海医药:商业、工业收入稳定增长,研发投入增加影响当期业绩",
                "features": {
                    "keywords": [
                        "上海医药",
                        "商业",
                        "工业",
                        "收入",
                        "研发投入",
                        "业绩"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}